PATENT CLAIM ANALYSIS

Application Number: 15780913
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "560000"]

Abstract:
The present invention relates generally to methods for the treatment and/or prophylaxis of mental illness involving administration of 10-HDA. More particularly, methods are taught herein for the treatment and/or prophylaxis of obsessive compulsive disorder, anxiety disorder or a condition characterised by one or more symptoms of a obsessive compulsive disorder or an anxiety disorder.

Claim (Index 24):
The method of  claim 20  wherein the pharmaceutical composition consists of 10-hydroxy-2-decenoic acid as the active ingredient and at least one pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 94.0
- Lexical Diversity: 1.52632
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15892144', '15316110', '14278573', '11399188', '14635905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7671050893231357
- 35 USC 102 Novelty (BERT): 0.5353923788269388
- Combined Prediction Score: 0.743933818273516
- Mean Citation Score: 322.267842
- Max Citation Score: 352.98038
- Similarity Product: 312.8422915619302

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test